These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 22864765)

  • 1. Navigating the Regulatory Pathways and Requirements for Tissue-Engineered Products in the Treatment of Burns in the United States.
    Belsky K; Smiell J
    J Burn Care Res; 2021 Aug; 42(4):774-784. PubMed ID: 33301575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies.
    Azuma K; Yamanaka S
    Regen Ther; 2016 Jun; 4():36-47. PubMed ID: 31245486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Journal of Artificial Organs 2012: the year in review.
    Sawa Y; Tatsumi E; Tsukiya T; Matsuda K; Fukunaga K; Kishida A; Masuzawa T; Matsumiya G; Myoui A; Nishimura M; Nishimura T; Nishinaka T; Okamoto E; Tokunaga S; Tomo T; Yagi Y; Yamaoka T;
    J Artif Organs; 2013 Mar; 16(1):1-8. PubMed ID: 23456197
    [No Abstract]   [Full Text] [Related]  

  • 4. New Japanese Regulatory Frameworks for Clinical Research and Marketing Authorization of Gene Therapy and Cellular Therapy Products.
    Nagai S; Ozawa K
    Curr Gene Ther; 2017; 17(1):17-28. PubMed ID: 28382858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM; Tolomeo D; Gluck E
    Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell and tissue therapy regulation: worldwide status and harmonization.
    Kellathur SN; Lou HX
    Biologicals; 2012 May; 40(3):222-4. PubMed ID: 22374355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Good practice in clinical investigation].
    Machín MP
    Medicina (B Aires); 2009; 69(6):688-9. PubMed ID: 20053616
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulatory frameworks for cell therapy products in Japan.
    Yanagi K; Fukuda E; Jotatsu Y; Shikano M; Miyake S
    J Artif Organs; 2012 Dec; 15(4):325-30. PubMed ID: 22864765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Doctor-initiated clinical trials and the revised pharmaceutical affairs law].
    Takano T; Saijo N
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1391-7. PubMed ID: 14584270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In order to perform clinical trials efficiently in Japan--important issues regarding monitoring by sponsors].
    Kaichi S; Oda T; Goto K; Sato K
    Nihon Kokyuki Gakkai Zasshi; 2007 Nov; 45(11):829-35. PubMed ID: 18051783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory Frameworks for Gene and Cell Therapies in Japan.
    Maeda D; Yamaguchi T; Ishizuka T; Hirata M; Takekita K; Sato D
    Adv Exp Med Biol; 2015; 871():147-62. PubMed ID: 26374217
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.